Look­ing to push check­point ef­fi­ca­cy, a qui­et mi­cro­bio­me up­start bags $67M for clin­i­cal work

Mi­cro­bi­ot­i­ca has some more funds to work with — $67 mil­lion more.

The qui­et mi­cro­bio­me ther­a­peu­tics spin­out with 48 em­ploy­ees an­nounced its Se­ries B ear­li­er this …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER